Pharmacology of heparin and related drugs

B Mulloy, J Hogwood, E Gray, R Lever, CP Page - Pharmacological reviews, 2016 - ASPET
Heparin has been recognized as a valuable anticoagulant and antithrombotic for several
decades and is still widely used in clinical practice for a variety of indications. The …

Oligosaccharide analysis by mass spectrometry: a review of recent developments

MJ Kailemia, LR Ruhaak, CB Lebrilla… - Analytical …, 2014 - ACS Publications
Carbohydrates are central players in a number of important biological processes including
cell signaling, cell adhesion, and the regulation of biochemical pathways. Unlike nucleic …

Applications of fourier transform ion cyclotron resonance (FT-ICR) and orbitrap based high resolution mass spectrometry in metabolomics and lipidomics

M Ghaste, R Mistrik, V Shulaev - International journal of molecular …, 2016 - mdpi.com
Metabolomics, along with other “omics” approaches, is rapidly becoming one of the major
approaches aimed at understanding the organization and dynamics of metabolic networks …

Targeting heparin and heparan sulfate protein interactions

RJ Weiss, JD Esko, Y Tor - Organic & biomolecular chemistry, 2017 - pubs.rsc.org
Heparin and heparan sulfate glycosaminoglycans are long, linear polysaccharides that are
made up of alternating dissacharide sequences of sulfated uronic acid and amino sugars …

Homogeneous low-molecular-weight heparins with reversible anticoagulant activity

Y Xu, C Cai, K Chandarajoti, PH Hsieh, L Li… - Nature chemical …, 2014 - nature.com
Low-molecular-weight heparins (LMWHs) are carbohydrate-based anticoagulants clinically
used to treat thrombotic disorders, but impurities, structural heterogeneity or functional …

Synthetic oligosaccharides can replace animal-sourced low–molecular weight heparins

Y Xu, K Chandarajoti, X Zhang, V Pagadala… - Science translational …, 2017 - science.org
Low–molecular weight heparin (LMWH) is used clinically to treat clotting disorders. As an
animal-sourced product, LMWH is a highly heterogeneous mixture, and its anticoagulant …

Analysis of glycosaminoglycan-derived, precolumn, 2-aminoacridone–labeled disaccharides with LC-fluorescence and LC-MS detection

N Volpi, F Galeotti, B Yang, RJ Linhardt - Nature protocols, 2014 - nature.com
Glycosaminoglycans (GAGs) possess considerable heterogeneity in average molecular
mass, molecular mass range, disaccharide composition and content and position of sulfo …

Spectroscopic characterization, cyclic voltammetry, biological investigations, MOE, and gaussian calculations of VO (II), Cu (II), and Cd (II) heteroleptic complexes

AG Al-Harazie, EA Gomaa, RR Zaky… - ACS …, 2023 - ACS Publications
A novel hydrazone ligand (o-H2BMP) N-(benzo [d] thiazol-2-yl)-3-oxo-3-(2-(1-(pyridin-2-yl)
ethylidene) hydrazinyl) propanamide alongside its Cu (II), Cd (II), and VO (II) complexes …

Analysis of the glycosaminoglycan chains of proteoglycans

Y Song, F Zhang, RJ Linhardt - Journal of Histochemistry & …, 2021 - journals.sagepub.com
Glycosaminoglycans (GAGs) are heterogeneous, negatively charged, macromolecules that
are found in animal tissues. Based on the form of component sugar, GAGs have been …

Developments in mass spectrometry for glycosaminoglycan analysis: a review

LE Pepi, P Sanderson, M Stickney, IJ Amster - Molecular & Cellular …, 2021 - ASBMB
This review covers recent developments in glycosaminoglycan (GAG) analysis via mass
spectrometry (MS). GAGs participate in a variety of biological functions, including cellular …